about
Capturing the biological impact of CDKN2A and MC1R genes as an early predisposing event in melanoma and non melanoma skin cancerGenomic analysis and clinical management of adolescent cutaneous melanoma.Mutational status of naevus-associated melanomas.Genomic expression differences between cutaneous cells from red hair color individuals and black hair color individuals based on bioinformatic analysis.KIT Mutations and CD117 Overexpression Are Markers of Better Progression-Free Survival in Vulvar Melanomas.Prevalence of MITF p.E318K in Patients With Melanoma Independent of the Presence of CDKN2A Causative Mutations.Multiple BRAF Wild-Type Melanomas During Dabrafenib Treatment for Metastatic BRAF-Mutant Melanoma.Inherited functional variants of the lymphocyte receptor CD5 influence melanoma survival.The MC1R melanoma risk variant p.R160W is associated with Parkinson disease.Melanocortin 1 receptor (MC1R) polymorphisms' influence on size and dermoscopic features of nevi.Amelanotic melanoma in oculocutaneous albinism: a genetic, dermoscopic and reflectance confocal microscopy study.A Common Variant in the MC1R Gene (p.V92M) is associated with Alzheimer's Disease Risk.Prognostic Role of Tumoral PDL1 Expression and Peritumoral FoxP3+ Lymphocytes in Vulvar Melanomas.IRF4 rs12203592 functional variant and melanoma survival.The p. R151C Polymorphism in MC1R Gene Modifies the Age of Onset in Spanish Huntington's Disease Patients.AURKA Overexpression Is Driven by FOXM1 and MAPK/ERK Activation in Melanoma Cells Harboring BRAF or NRAS Mutations: Impact on Melanoma Prognosis and Therapy.Time and tumor type (primary or metastatic) do not influence the detection of BRAF/NRAS mutations in formalin fixed paraffin embedded samples from melanomas.Genome-wide linkage analysis in Spanish melanoma-prone families identifies a new familial melanoma susceptibility locus at 11qGenetic Abnormalities in Large to Giant Congenital Nevi: Beyond NRAS mutationsDiscrepant mutational status between naevi and melanomas in naevus-associated melanomas: about mutation-specific immunohistochemistry: reply from the authorsReplyDetection of cell-free circulating BRAFV 600E by droplet digital polymerase chain reaction in patients with and without melanoma under dermatological surveillance
P50
Q28238393-192C6D09-5A40-46A7-8152-38879361718AQ33701435-F1F3701B-4D8A-47DB-BBDB-E8728B5DA301Q36095004-CC30FB63-E571-43CB-ABB4-6340B10D4982Q37706956-53CF902A-4B87-4031-8135-02571BD14E54Q38372948-C28AA012-8EEF-40A0-9FF5-3166E78807E1Q40229413-87941448-80D5-4684-8ACB-C4664853523FQ40254885-E2C2458C-0DF1-4E05-BD8D-33779EA7FCB3Q40759062-D3187C1E-ACE9-42F6-A276-5358752D92AAQ41512301-B9171254-78B1-41AD-BCAC-763E02E34BEFQ47185741-DD57FF83-2726-423F-9AB0-0B15080E2E04Q48363280-A3C7B83A-21F7-48D4-8897-FC480CE60777Q48369672-C39F4385-581F-4E45-857D-844725BC56B9Q50145082-92F14D2A-D316-4E97-9D77-11520A4608E1Q50218628-60B76991-F72F-49B4-98DF-B6D19E9F8C30Q50221973-04FA573B-D387-48B1-AD4C-E51F7838B612Q51141412-064882DF-B786-4F72-9EFA-D131DFEDEA0BQ54199206-6D5C708B-675C-477F-A031-CD737B0856CFQ57172080-B746813D-AED0-4346-875A-AAE8A747E6CFQ57803822-F59E5BE8-E97F-43C2-A08E-2424E4890064Q60566863-23EAEA84-D232-4C50-AE22-5220225623D8Q60566929-3676C94F-B81D-4761-BA6C-CEA6C58ECABEQ92128484-62FBD769-CBDF-47B8-9A92-2FC6334AAFAE
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Gemma Tell-Martí
@ast
Gemma Tell-Martí
@en
Gemma Tell-Martí
@es
Gemma Tell-Martí
@nl
Gemma Tell-Martí
@sl
type
label
Gemma Tell-Martí
@ast
Gemma Tell-Martí
@en
Gemma Tell-Martí
@es
Gemma Tell-Martí
@nl
Gemma Tell-Martí
@sl
altLabel
Gemma Tell-Marti
@en
prefLabel
Gemma Tell-Martí
@ast
Gemma Tell-Martí
@en
Gemma Tell-Martí
@es
Gemma Tell-Martí
@nl
Gemma Tell-Martí
@sl
P106
P1153
56270045300
P21
P31
P496
0000-0003-2728-6961